•  
  •  
  •  
  •  

2026-07-19 16:28:12

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • LTM Partners with Glean to Accelerate Enterprise AI Adoption
  • Rajesh Power Services Ltd receives orders from PGVCL
  • Muthoot Capital Services Q1 FY27 Results: Net Profit Surges 51.4% Sequentially to ₹812.21 Lakhs, Turning Profitable Year-on-Year
  • PNB Gilts Q1 FY27 Results: Net Profit Surges Over 500% Sequentially to ₹8,069.80 Lakhs, Driven by Strong Operating Performance
  • WeWork India Management Limited Q1 FY27 Results: Revenue Rises 27.7% YoY to ₹6,838.32 Million; Narrower Losses Driven by High Lease/Finance Overheads

Keywords Selected:  Neuland

Stock Report

  • CARBOGEN AMCIS AG Site Commissions Ground-Mounted Photovoltaic System at Its Neuland Site
  • Neuland Laboratories Ltd recommends final dividend of Rs. 34
  • Neuland Laboratories Ltd consolidated Q4 FY26 PAT surges to Rs. 212.67 crores
  • Saharsh Davuluri takes over as CEO & MD of Neuland and will lead the next phase of CDMO expansion
  • Neuland Q2FY26 Total income at Rs.516.1 crore; EBITDA at Rs.156.9 crore
  • Neuland Laboratories Ltd receives EIR from USFDA for Unit 2 at Pashamylaram Village
  • CARBOGEN AMCIS AG., has entered into a co-investment agreement of more than CHF 25 million with a key client to expand Swiss sites
  • Neuland Laboratories Ltd recommends final dividend of Rs. 12
  • Neuland Laboratories Ltd Q4 FY2025 consolidated net profit declines to Rs. 27.80 crores
  • Neuland Laboratories Ltd completes USFDA inspection at Unit 2
  • Neuland Laboratories Limited transfers final part of property at Nanakramguda, Hyderabad
  • Neuland Laboratories Ltd Q2 FY2025 consolidated PAT declines to Rs. 32.84 crores
  • Neuland Laboratories Ltd Q1 FY25 consolidated PAT surges to Rs. 97.87 crores
  • Neuland unveils a refreshed brand identity
  • Neuland Laboratories Ltd recommends final dividend of Rs. 14
  • Neuland Laboratories Ltd Q4 FY2024 consolidated PAT falls to Rs. 67.56 crores
  • Neuland Laboratories Ltd's Unit 1 successfully completes USFDA inspection
  • Neuland Laboratories Ltd's promoter has sold 4 lakh shares
  • Neuland Laboratories Ltd Q1 FY2024 consolidated PAT falls QoQ to Rs. 61.87 crores
  • Neuland Laboratories Ltd gets EIR from USFDA for Unit 3
  • Neuland Laboratories Limited updates on USFDA inspection
  • Neuland Laboratories Ltd recommends final dividend of Rs. 10
  • Neuland Laboratories Ltd consolidated Q4FY23 PAT surges to Rs. 84.54 crores
  • Neuland Laboratories Ltd awarded S&P Global ESG Score, 2022

Latest Post

  • LTM Partners with Glean to Accelerate Enterprise AI Adoption
  • Rajesh Power Services Ltd receives orders from PGVCL
  • Muthoot Capital Services Q1 FY27 Results: Net Profit Surges 51.4% Sequentially to ₹812.21 Lakhs, Turning Profitable Year-on-Year
  • PNB Gilts Q1 FY27 Results: Net Profit Surges Over 500% Sequentially to ₹8,069.80 Lakhs, Driven by Strong Operating Performance
  • WeWork India Management Limited Q1 FY27 Results: Revenue Rises 27.7% YoY to ₹6,838.32 Million; Narrower Losses Driven by High Lease/Finance Overheads


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025